- Report
- September 2021
- 163 Pages
Global
From €5719EUR$5,950USD£4,904GBP
- Report
- May 2024
- 262 Pages
From €5382EUR$5,600USD£4,616GBP
- Report
- April 2019
- 73 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- August 2022
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- March 2023
- 119 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- March 2023
- 112 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- February 2018
- 15 Pages
Global
- Report
- September 2021
- 104 Pages
Global
From €4325EUR$4,500USD£3,709GBP
- Drug Pipelines
- January 2018
- 10 Pages
Global
From €9612EUR$10,000USD£8,242GBP
- Report
- February 2023
- 126 Pages
Europe
From €2018EUR$2,100USD£1,731GBP
€2883EUR$3,000USD£2,473GBP
- Report
- April 2022
- 70 Pages
Middle East, Africa
From €1442EUR$1,500USD£1,236GBP
- Report
- December 2018
- 125 Pages
Global
From €7684EUR$7,995USD£6,590GBP
- Report
- January 2020
- 40 Pages
Saudi Arabia
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
Japan
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
India
From €2494EUR$2,595USD£2,139GBP
- Report
- January 2020
- 40 Pages
France
From €2494EUR$2,595USD£2,139GBP
- Report
- June 2023
- 187 Pages
China
From €1730EUR$1,800USD£1,484GBP
- Report
- June 2023
- 326 Pages
China
From €3845EUR$4,000USD£3,297GBP
- Drug Pipelines
- January 2018
- 83 Pages
Global
From €21145EUR$22,000USD£18,133GBP
- Report
- February 2024
- 111 Pages
Global
From €3500EUR$3,901USD£3,106GBP
DNA vaccines are a type of genomics-based vaccine that uses genetic material from a virus or bacteria to stimulate an immune response. They are created by introducing a gene that codes for a specific antigen into a plasmid, which is then inserted into a host cell. The host cell then produces the antigen, which is then used to stimulate an immune response. DNA vaccines are considered to be safer than traditional vaccines, as they do not contain any live virus or bacteria. Additionally, they can be produced more quickly and cheaply than traditional vaccines.
DNA vaccines have been used to treat a variety of diseases, including influenza, malaria, and HIV. They have also been used to develop vaccines for cancer and other diseases. Recently, DNA vaccines have been used to develop vaccines for the prevention of infectious diseases, such as Zika virus and Ebola.
Companies in the DNA Vaccines market include Moderna, Inovio Pharmaceuticals, Novavax, and Transgene. Show Less Read more